- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 265/28 - Oxazines-1, 4Oxazines-1, 4 hydrogénées
Détention brevets de la classe C07D 265/28
Brevets de cette classe: 65
Historique des publications depuis 10 ans
|
4
|
7
|
2
|
3
|
9
|
3
|
4
|
3
|
4
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 789 |
4 |
| Ricoh Company, Ltd. | 13421 |
2 |
| Adverio Pharma GmbH | 47 |
2 |
| Alcon, Inc. | 5953 |
2 |
| BioCryst Pharmaceuticals, Inc. | 186 |
2 |
| Oregon Health & Science University | 755 |
2 |
| ProteinSimple | 89 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 884 |
2 |
| West China Hospital, Sichuan University | 243 |
2 |
| Kemimedi Co.Ltd | 3 |
2 |
| Cullgen (Shanghai), Inc. | 41 |
2 |
| Merck Sharp & Dohme LLC | 3734 |
2 |
| Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. | 8 |
2 |
| Glaxosmithkline LLC | 525 |
1 |
| Hoffmann-La Roche Inc. | 3876 |
1 |
| Baker Hughes Incorporated | 4861 |
1 |
| 3m Innovative Properties Company | 17455 |
1 |
| BASF SE | 21334 |
1 |
| The Regents of the University of California | 20987 |
1 |
| International Business Machines Corporation | 62871 |
1 |
| Autres propriétaires | 30 |